Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Program
On WRAL at 7: After-school program keeping kids out of gangs. How nonprofits are helping children make the right choices & helping their families
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nestle Sa Cham Et Ve
(OP:
NSRGF
)
103.18
+0.22 (+0.21%)
Streaming Delayed Price
Updated: 3:56 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,408
Open
102.30
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
102.96
Today's Range
102.30 - 103.73
52wk Range
95.73 - 122.69
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
June 21, 2024
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media.
Via
Benzinga
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
May 21, 2024
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide.
Via
Benzinga
Performance
YTD
-10.36%
-10.36%
1 Month
-2.50%
-2.50%
3 Month
-2.83%
-2.83%
6 Month
-5.60%
-5.60%
1 Year
-11.86%
-11.86%
More News
Read More
Keurig Dr Pepper Reaffirms Its Guidance, Time to Buy?
April 01, 2024
Via
MarketBeat
Magnificent 7 Stocks Become The Star Attractions For Norway's Sovereign Wealth Fund
March 25, 2024
Via
Benzinga
Is My Candy Bar Getting Smaller? Yes, A Chocolate Crisis Means Smaller, Pricier Hershey's
February 29, 2024
Via
Benzinga
Economic Armor: 7 Defensive Consumer Stocks to Weather Any Storm
November 27, 2023
Via
InvestorPlace
Arm's IPO Could Be Valued At $54B, Google Slashes Jobs in Global Recruiting, Starbucks Founder And Former CEO To Leave: Today's Top Stories
September 14, 2023
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
'Shrinkflation' Shame!: French Supermarket Carrefour Targets PepsiCo, Unilever and Others By Issuing Price Alerts
September 14, 2023
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event, TikTok Takes On Twitter, Analysts Expect Nvidia's AI Revenues To Reach $300B In Five Years: Today's Top Stories
July 25, 2023
Via
Benzinga
Nestle, Danone Price Rises To Put Them Under France's Inflation Scanner: Report
July 25, 2023
Via
Benzinga
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
May 24, 2023
Via
Benzinga
Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report
January 21, 2023
Via
Benzinga
SpaceX Starlink's New In-Flight Connectivity Service, Amazon's NY Workers Reject Union, Celsius Network Faces Several Federal Investigations: Top Stories Wednesday, Oct. 19
October 19, 2022
Via
Benzinga
Consumers Should Be Ready For Further Price Increases, Nestle's Chief Executive Says
October 19, 2022
Via
Benzinga
Nestle Bets €40M On Enterome's Preclinical Food Allergy, IBD Hopeful
July 18, 2022
Via
Benzinga
Third Largest Player In Baby Formula Jumps In To Ease Shortage In US
May 18, 2022
Via
Benzinga
Very Good Food Appoints Former Nestle Executive As Interim CEO
April 25, 2022
Via
Benzinga
More Non-US Companies Restricted Services In Russia After US Counterparts
March 10, 2022
Via
Benzinga
New Sources of Alternative Proteins Coming in 2022, as Plant-Based Producers Promote New Ideas
January 11, 2022
Via
FinancialNewsMedia
Dada Nexus, Nestlé Expand Partnership To Boost Omni-Channel Growth
October 28, 2021
Via
Benzinga
Nestlé Bets $525M On Seres Therapeutics Microbiome Drug For Infectious Diseases
July 01, 2021
Via
Benzinga
Exposures
Product Safety
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.